A Dark Vector Cognition product

Item 1. Financial Statements

154K characters. Original on sec.gov ·

Item 1. Financial Statements

The 44 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

STATEMENT OF EARNINGS (LOSS) (UNAUDITED)Three months ended March 31
(In millions, per-share amounts in dollars)20232022
Sales of equipment$5,287$4,608
Sales of services8,4077,302
Insurance revenues (Note 13)791764
Total revenues (Note 8)14,48612,675
Cost of equipment sold5,6055,148
Cost of services sold5,1244,626
Selling, general and administrative expenses2,1422,725
Separation costs (Note 20)20599
Research and development431403
Interest and other financial charges269387
Insurance losses, annuity benefits and other costs (Note 13)684620
Non-operating benefit cost (income)(385)(105)
Total costs and expenses14,07513,904
Other income (loss) (Note 19)6,08149
Earnings (loss) from continuing operations before income taxes6,492(1,180)
Benefit (provision) for income taxes (Note 16)(271)(29)
Earnings (loss) from continuing operations6,221(1,209)
Earnings (loss) from discontinued operations, net of taxes (Note 2)1,257101
Net earnings (loss)7,478(1,108)
Less net earnings (loss) attributable to noncontrolling interests(27)28
Net earnings (loss) attributable to the Company7,506(1,136)
Preferred stock dividends and other(145)(52)
Net earnings (loss) attributable to GE common shareholders$7,360$(1,188)
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations$6,221$(1,209)
Less net earnings (loss) attributable to noncontrolling interests,
continuing operations(27)14
Earnings (loss) from continuing operations attributable to the Company6,248(1,224)
Preferred stock dividends and other(145)(52)
Earnings (loss) from continuing operations attributable
to GE common shareholders6,103(1,276)
Earnings (loss) from discontinued operations attributable
to GE common shareholders1,25788
Net earnings (loss) attributable to GE common shareholders$7,360$(1,188)
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share$5.56$(1.16)
Basic earnings (loss) per share$5.60$(1.16)
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share$6.71$(1.08)
Basic earnings (loss) per share$6.76$(1.08)

2023 1Q FORM 10-Q 20

STATEMENT OF FINANCIAL POSITION (UNAUDITED)
(In millions)March 31, 2023December 31, 2022
Cash, cash equivalents and restricted cash$12,001$15,810
Investment securities (Note 3)12,8147,609
Current receivables (Note 4)14,21214,831
Inventories, including deferred inventory costs (Note 5)16,19814,891
Current contract assets (Note 9)2,2442,467
All other current assets (Note 10)1,4641,400
Assets of businesses held for sale (Note 2)1,3531,374
Current assets60,28658,384
Investment securities (Note 3)38,26236,027
Property, plant and equipment – net (Note 6)12,17012,192
Goodwill (Note 7)13,10712,999
Other intangible assets – net (Note 7)5,9906,105
Contract and other deferred assets (Note 9)5,6315,776
All other assets (Note 10)15,88815,477
Deferred income taxes (Note 16)10,34410,001
Assets of discontinued operations (Note 2)2,79331,890
Total assets$164,472$188,851
Short-term borrowings (Note 11)$2,262$3,739
Accounts payable and equipment project payables (Note 12)15,06315,399
Progress collections and deferred income (Note 9)16,58616,216
All other current liabilities (Note 15)12,31312,130
Liabilities of businesses held for sale (Note 2)1,9531,944
Current liabilities48,17749,428
Deferred income (Note 9)1,5001,409
Long-term borrowings (Note 11)20,15920,320
Insurance liabilities and annuity benefits (Note 13)39,08236,845
Non-current compensation and benefits10,24410,400
All other liabilities (Note 15)10,93711,063
Liabilities of discontinued operations (Note 2)1,55124,474
Total liabilities131,649153,938
Preferred stock (Note 17)36
Common stock (Note 17)1515
Accumulated other comprehensive income (loss) – net attributable to GE (Note 17)(3,289)(2,272)
Other capital30,72934,173
Retained earnings84,95582,983
Less common stock held in treasury(80,762)(81,209)
Total GE shareholders’ equity31,65233,696
Noncontrolling interests1,1711,216
Total equity32,82334,912
Total liabilities and equity$164,472$188,851

2023 1Q FORM 10-Q 21

STATEMENT OF CASH FLOWS (UNAUDITED)Three months ended March 31
(In millions)20232022
Net earnings (loss)$7,478$(1,108)
(Earnings) loss from discontinued operations activities(1,257)(101)
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities
Depreciation and amortization of property, plant and equipment367403
Amortization of intangible assets (Note 7)140922
(Gains) losses on purchases and sales of business interests52(15)
(Gains) losses on equity securities(5,906)206
Principal pension plans cost (Note 14)(271)94
Principal pension plans employer contributions(52)(49)
Other postretirement benefit plans (net)(181)(224)
Provision (benefit) for income taxes27129
Cash recovered (paid) during the year for income taxes(172)(24)
Changes in operating working capital:
Decrease (increase) in current receivables536(610)
Decrease (increase) in inventories, including deferred inventory costs(1,275)(732)
Decrease (increase) in current contract assets294473
Increase (decrease) in accounts payable and equipment project payables(201)(293)
Increase (decrease) in progress collections and current deferred income205173
Financial services derivatives net collateral/settlement3(155)
All other operating activities12589
Cash from (used for) operating activities – continuing operations155(924)
Cash from (used for) operating activities – discontinued operations(413)369
Cash from (used for) operating activities(259)(556)
Additions to property, plant and equipment(279)(239)
Dispositions of property, plant and equipment728
Additions to internal-use software(20)(22)
Sales of retained ownership interests2,0251,302
Net (purchases) dispositions of insurance investment securities(1,556)(1,344)
All other investing activities1,096239
Cash from (used for) investing activities – continuing operations1,273(37)
Cash from (used for) investing activities – discontinued operations(3,068)(407)
Cash from (used for) investing activities(1,796)(444)
Net increase (decrease) in borrowings (maturities of 90 days or less)145
Newly issued debt (maturities longer than 90 days)9—
Repayments and other debt reductions (maturities longer than 90 days)(1,815)(1,267)
Dividends paid to shareholders(203)(140)
Redemption of GE preferred stock(3,000)—
Purchases of GE common stock for treasury(309)(39)
All other financing activities87(30)
Cash from (used for) financing activities – continuing operations(5,230)(1,431)
Cash from (used for) financing activities – discontinued operations1,999(28)
Cash from (used for) financing activities(3,232)(1,459)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash65(75)
Increase (decrease) in cash, cash equivalents and restricted cash(5,220)(2,534)
Cash, cash equivalents and restricted cash at beginning of year19,09216,859
Cash, cash equivalents and restricted cash at March 3113,87114,325
Less cash, cash equivalents and restricted cash of discontinued operations at March 311,1801,223
Cash, cash equivalents and restricted cash of continuing operations at March 31$12,691$13,101

2023 1Q FORM 10-Q 22

STATEMENT OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)Three months ended March 31
(In millions)20232022
Net earnings (loss)$7,478$(1,108)
Less: net earnings (loss) attributable to noncontrolling interests(27)28
Net earnings (loss) attributable to the Company$7,506$(1,136)
Currency translation adjustments2,387(181)
Benefit plans(2,319)240
Investment securities and cash flow hedges706(2,998)
Long-duration insurance contracts(a)(1,793)3,682
Less: other comprehensive income (loss) attributable to noncontrolling interests(3)(2)
Other comprehensive income (loss) attributable to the Company$(1,017)$745
Comprehensive income (loss)$6,458$(365)
Less: comprehensive income (loss) attributable to noncontrolling interests(30)26
Comprehensive income (loss) attributable to the Company$6,489$(391)

(a) Represents the net after-tax change in future policy benefit reserves and related reinsurance recoverables from updating the discount rate. See Notes 1 and 13 for further information.

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)Three months ended March 31
(In millions)20232022
Preferred stock issued(a)$3$6
Common stock issued$15$15
Beginning balance(2,272)(4,860)
Currency translation adjustments2,388(177)
Benefit plans(2,317)238
Investment securities and cash flow hedges706(2,998)
Long-duration insurance contracts(1,793)3,682
Accumulated other comprehensive income (loss)$(3,289)$(4,115)
Beginning balance34,17334,691
Gains (losses) on treasury stock dispositions(619)(396)
Stock-based compensation7391
Other changes(a)(2,898)5
Other capital$30,729$34,391
Beginning balance82,98383,286
Net earnings (loss) attributable to the Company7,506(1,136)
Dividends and other transactions with shareholders(b)(5,534)(141)
Retained earnings$84,955$82,009
Beginning balance(81,209)(81,093)
Purchases(311)(39)
Dispositions759459
Common stock held in treasury$(80,762)$(80,673)
GE shareholders' equity balance31,65231,631
Noncontrolling interests balance1,1711,278
Total equity balance at March 31$32,823$32,909

(a) Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.

(b) Included $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.

2023 1Q FORM 10-Q 23

NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event.

In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.

We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information.

On January 3, 2023, General Electric Company (the Company or GE) completed the previously announced separation (the Separation) of its HealthCare business, into a separate, independent publicly traded company. The historical results of GE HealthCare and certain assets and liabilities included in the spin-off are now reported in GE's consolidated financial statements as discontinued operations. See Note 2 for further information.

The accompanying consolidated financial statements and notes are unaudited. The results reported in these financial statements should not be regarded as necessarily indicative of results that may be expected for the entire year. These financial statements should be read in conjunction with the financial statements, notes and significant accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2022.

INSURANCE. Our run-off insurance operations include providing insurance and reinsurance for life and health risks and providing certain annuity products. Primary product types include long-term care, structured settlement annuities, life and disability insurance contracts and investment contracts. Insurance contracts are contracts with significant mortality and/or morbidity risks, while investment contracts are contracts without such risks. Insurance revenues are comprised primarily of premiums and investment income. For traditional long-duration insurance contracts, we report premiums as revenue when due. Premiums received on non-traditional long-duration insurance contracts and investment contracts, including annuities without significant mortality risk, are not reported as revenues but rather as deposit liabilities. We recognize revenues for charges and assessments on these contracts, mostly for mortality, administration and surrender. Interest credited to policyholder accounts is charged to expense.

Future policy benefit reserves represent the present value of future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums. The liability is measured by each group of contracts (i.e., cohorts) using current cash flow assumptions. As a run-off insurance operation consisting substantially all of reinsurance, contracts are grouped into cohorts by legal entity and product type, based on the date the reinsurance contract was consummated. Future policy benefit reserves are adjusted each period as a result of updating lifetime net premium ratios for differences between actual and expected experience with the retroactive effect of those variances recognized in current period earnings. We review at least annually in the third quarter, future policy benefit reserves cash flow assumptions, except related claim expenses which remain locked-in, and if the review concludes that the assumptions need to be updated, future policy benefit reserves are adjusted retroactively based on the revised net premium ratio using actual historical experience, updated cash flow assumptions, and the locked-in discount rate with the effect of those changes recognized in current period earnings.

As our insurance operations are in run-off, the locked-in discount rate is the discount rate used for the computation of interest accretion on future policy benefit reserves recognized in earnings. However, cash flows used to estimate future policy benefit reserves are also discounted using an upper-medium grade (i.e., low credit risk) fixed-income instrument yield reflecting the duration characteristics of the liabilities and is updated each reporting period with changes recorded in AOCI. As a result, changes in the current discount rate at each reporting period will be recognized as an adjustment to AOCI and not earnings each period, whereas changes relating to cash flow assumptions will be recognized in the Statement of Earnings (Loss).

2023 1Q FORM 10-Q 24

Reinsurance recoverables are recorded when we cede insurance risk to third parties but are not relieved from our primary obligation to policyholders and cedents. As reinsurance recoverables are recognized in a manner consistent with the future policy benefit reserves relating to the underlying reinsurance contracts, changes in reinsurance recoverables from updating the discount rate in each reporting period are also recognized in AOCI. The allowance for credit losses on reinsurance recoverables is based on the locked-in future policy benefit reserves discount rate for purposes of assessing changes in each reporting period. As such, movements in the gross reinsurance recoverable balance resulting from changes in the discount rate do not impact the allowance for credit losses. Following the recapture transaction effective in the fourth quarter of 2022, the remaining reinsurance recoverables are not material.

Liabilities for investment contracts equal the account value, that is, the amount that accrues to the benefit of the contract or policyholder including credited interest and assessments through the financial statement date. See Note 13 for further information.

ADOPTIONS OF NEW ACCOUNTING STANDARDS. On January 1, 2023, we adopted Accounting Standards Update No. 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts. The new guidance for measuring the liability for future policy benefits and related reinsurance recoverable asset was adopted on a modified retrospective basis such that those balances were adjusted to conform to the new guidance at the January 1, 2021 transition date.

We recognized a $7,285 million after-tax decrease in Total equity at January 1, 2021 from the effect of transition date adjustments due to adoption of the new guidance, as presented in the following table.

Retained EarningsAOCI
December 31, 2020$92,247$(9,749)
Liability for future policy benefits, including removal of related balances in AOCI(1,853)(8,806)
Reinsurance recoverables, net of allowance for credit losses483,542
Other contracts, including market risk benefits(202)(14)
Effect of transition adjustments$(2,007)$(5,278)
Adjusted balance, January 1, 2021$90,240$(15,027)

The following table summarizes the balance of and pre-tax changes to total Insurance liabilities and annuity benefits attributable to changes in the liability for future policy benefits and market risk benefits at the transition date, due to adoption of the new guidance.

Long-term careStructured settlement annuitiesLifeOther contracts(a)Other adjustmentsTotal
December 31, 2020$21,378$9,124$517$3,012$8,160$42,191
Change in discount rate assumptions14,6544,369283——19,306
Change in cash flow assumptions (effect of insufficient gross premiums) and elimination of negative reserves1,54539761——2,345
Adjustment for removal of related balances in AOCI————(8,160)(8,160)
Market risk benefits and other———269—269
Adjusted balance, January 1, 202137,57713,5321,5613,281—55,951
Less: reinsurance recoverables, net7,036—1544—7,095
Adjusted balance, January 1, 2021, net of reinsurance recoverables$30,541$13,532$1,546$3,237$—$48,856

(a) As of December 31, 2020, includes investment contracts ($2,049 million), claim reserves related to short-duration contracts at Electric Insurance Company (EIC), net of eliminations ($399 million), and other ($564 million). EIC is a property and casualty insurance company primarily providing insurance to GE and its employees.

For the liability for future policy benefits and related reinsurance recoverables, the new guidance transition adjustments are reflected in both AOCI and Retained earnings. The transition adjustment reflected in AOCI is related to the difference in the discount rate used pre-transition and the discount rate required under the new guidance, which is equivalent to an upper-medium grade fixed-income instrument yield reflecting the duration characteristics of our insurance liabilities, at January 1, 2021, and does not represent a change in our ultimate expected cash flows associated with the liability for future policy benefits or related reinsurance recoverables. The transition adjustment in AOCI also reflects removal of certain Other adjustments previously recorded in the liability for future policy benefits related to changes in net unrealized gains on investment securities.

Whereas pre-transition, we annually performed premium deficiency testing in the aggregate across our run-off insurance portfolio, the new guidance requires the grouping of contracts (i.e., cohorts) at a more granular level. Due to this lower level of aggregation, combined with the conversion of our long-term care insurance claim cost projection models to first principles models, we identified certain cohorts at transition having insufficient gross premiums in our long-term care insurance portfolio. A first principles model separates morbidity assumptions such as incidence (probability of a claim), continuance (length of a claim) and utilization (percentage of the daily benefit maximum used) into individual assumptions. We also eliminated negative reserves, as required by the new guidance, on certain cohorts in our life portfolio. As a result, we increased the liability for future policy benefits and reflected this transition adjustment in Retained earnings.

2023 1Q FORM 10-Q 25

At the transition date, reinsurance recoverables of $4,062 million increased by $4,483 million upon remeasurement to the updated discount rate, with an offsetting adjustment ($3,542 million after-tax) recognized in AOCI. As reinsurance recoverables are recognized in a manner consistent with the liabilities relating to the underlying reinsurance contracts, adjustments to the liability for future policy benefits due to the change in cash flow assumptions resulted in an increase to reinsurance recoverables of $629 million ($497 million after-tax) and an increase in the related allowance for credit losses of $569 million ($450 million after-tax), which was recorded as an adjustment to Retained earnings at the transition date. As a result, the adjusted balance of reinsurance recoverables at the transition date was $7,095 million, net of the allowance for credit losses of $2,079 million, and substantially all related to our long-term care insurance portfolio. Following the recapture transaction effective in the fourth quarter of 2022, the remaining reinsurance recoverables are not material.

The new guidance is only applicable to the measurements of our long-duration insurance liabilities and related reinsurance recoverables under GAAP and does not affect the accounting for our insurance reserves or the levels of capital and surplus under statutory accounting practices. See Note 13 for further information.

NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the first quarter of 2022, we signed a non-binding memorandum of understanding to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). In the fourth quarter of 2022, we signed a binding agreement for this transaction, and we expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the second half of 2023. Closing the transaction is expected to result in a significant gain.

In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, with assets of $596 million and liabilities of $342 million as of March 31, 2023, into held for sale. We expect to complete the sale of this business, subject to regulatory approvals, by the first half of 2024. In connection with the expected sale, in the first quarter of 2023, we recorded a loss of $55 million in Other income (loss) in our Statement of Earnings.

ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALEMarch 31, 2023December 31, 2022
Current receivables, inventories and contract assets$527$495
Non-current captive insurance investment securities578554
Property, plant and equipment and intangible assets - net240232
Valuation allowance on disposal group classified as held for sale(72)(17)
All other assets80111
Assets of businesses held for sale$1,353$1,374
Progress collections and deferred income$1,101$1,127
Insurance liabilities and annuity benefits340358
Accounts payable, equipment project payables and other current liabilities421371
All other liabilities9087
Liabilities of businesses held for sale$1,953$1,944

DISCONTINUED OPERATIONS primarily comprise our former GE HealthCare business, our mortgage portfolio in Poland, our GE Capital Aviation Services (GECAS) business, and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis.

GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business, into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation are reported in GE's consolidated financial statements as discontinued operations.

We have continuing involvement with GE HealthCare primarily through trademark license and transition services agreements, through which GE and GE HealthCare will continue to provide certain services to each other for a period of time following the Separation. For the three months ended March 31, 2023, we collected net cash of $160 million related to these activities.

2023 1Q FORM 10-Q 26

Bank BPH. The mortgage portfolio in Poland (Bank BPH) comprises floating rate residential mortgages, 86% of which are indexed to or denominated in foreign currencies (primarily Swiss francs). At March 31, 2023, the total portfolio had a carrying value, net of reserves, of $1,126 million. The portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields as well as estimates with respect to ongoing litigation in Poland related to foreign currency-denominated mortgages and other factors. Loss from discontinued operations included $175 million and $233 million non-cash pre-tax charges for the three months ended March 31, 2023 and 2022, respectively, reflecting estimates with respect to ongoing litigation as well as market yields. To ensure appropriate capital levels, during the first quarter of 2023, we made a non-cash capital contribution in the form of intercompany loan forgiveness of $198 million. We made a cash capital contribution of $530 million into Bank BPH in the twelve months ended December 31, 2022. Future changes in the estimated legal liabilities or market yields could result in further capital contributions and losses in future reporting periods beyond the amounts that we currently estimate. See Note 23 for further information.

GECAS/AerCap. We have continuing involvement with AerCap, primarily through our ownership interest, ongoing sales or leases of products and services, and transition services that we provide to AerCap. For the three months ended March 31, 2023, we had direct and indirect sales of $48 million to AerCap, primarily related to engine services and sales, and purchases of $67 million from AerCap, primarily related to engine leases. We paid net cash of $88 million to AerCap related to this activity.

20232022
RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31GE HealthCareBank BPH & OtherTotalGE HealthCareBank BPH & OtherTotal
Total revenues$—$—$—$4,361$—$4,361
Cost of equipment and services sold———(2,679)—(2,679)
Other income, costs and expenses(20)(201)(221)(1,146)(250)(1,396)
Earnings (loss) of discontinued operations before income taxes(20)(201)(221)536(250)286
Benefit (provision) for income taxes(a)1,479(1)1,478(150)(18)(167)
Earnings (loss) of discontinued operations, net of taxes1,459(202)1,257387(268)119
Gain (loss) on disposal before income taxes————(23)(23)
Benefit (provision) for income taxes————55
Gain (loss) on disposal, net of taxes————(18)(18)
Earnings (loss) from discontinued operations, net of taxes$1,459$(202)$1,257$387$(286)$101

(a) The tax benefit for the three months ended March 31, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain.

ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONSMarch 31, 2023December 31, 2022
Cash, cash equivalents and restricted cash$1,180$2,627
Current receivables133,361
Inventories, including deferred inventory costs—2,512
Goodwill—12,799
Other intangible assets - net—1,520
Contract and other deferred assets—854
Financing receivables held for sale (Polish mortgage portfolio)(a)1,1261,200
Property, plant, and equipment - net692,379
All other assets3442,109
Deferred income taxes622,528
Assets of discontinued operations(b)$2,793$31,890
Accounts payable and equipment project payables$102$3,487
Progress collections and deferred income—2,499
Long-term borrowings—8,273
Non-current compensation and benefits365,658
All other liabilities(a)1,4134,556
Liabilities of discontinued operations(b)$1,551$24,474

(a) Included $889 million of valuation allowance against financing receivables held for sale (including $645 million related to foreign currency-denominated mortgage litigation) and $895 million of litigation reserves recorded in All other liabilities in Poland at March 31, 2023.

(b) Included $133 million and $28,998 million of assets and $279 million and $23,337 million of liabilities for GE HealthCare as of March 31, 2023 and December 31, 2022, respectively.

2023 1Q FORM 10-Q 27

NOTE 3. INVESTMENT SECURITIES. All of our debt securities are classified as available-for-sale and substantially all are investment-grade supporting obligations to annuitants and policyholders in our run-off insurance operations. We manage the investments in our run-off insurance operations under strict investment guidelines, including limitations on asset class concentration, single issuer exposures, asset-liability duration variances, and other factors to meet credit quality, yield, liquidity and diversification requirements associated with servicing our insurance liabilities under reasonable circumstances. This process includes consideration of various asset allocation strategies and incorporates information from several external investment advisors to improve our investment yield subject to maintaining our ability to satisfy insurance liabilities when due, as well as considering our risk-based capital requirements, regulatory constraints, and tolerance for surplus volatility. Asset allocation planning is a dynamic process that considers changes in market conditions, risk appetite, liquidity needs and other factors, which are reviewed on a periodic basis by our investment team. Our investment in GE HealthCare comprised 90.3 million shares (approximately 19.9% ownership interest) at March 31, 2023. Our investment in AerCap comprised 79.7 million ordinary shares (approximately 33% ownership interest) at March 31, 2023 and an AerCap senior note, for which we have adopted the fair value option. We sold our remaining shares in Baker Hughes (BKR) during the first quarter of 2023. Our GE HealthCare, AerCap and BKR investments are recorded as Equity securities with readily determinable fair values. Investment securities held within insurance entities are classified as non-current as they support the long-duration insurance liabilities.

March 31, 2023December 31, 2022
Amortized costGross unrealized gainsGross unrealized lossesEstimated fair valueAmortized costGross unrealized gainsGross unrealized lossesEstimated fair value
Equity (GE HealthCare)$—$—$—$7,410$—$—$—$—
Equity and note (AerCap)———5,404———7,403
Equity (Baker Hughes)———————207
Current investment securities$—$—$—$12,814$—$—$—$7,609
Debt
U.S. corporate$27,760$996$(1,781)$26,975$26,921$675$(2,164)$25,432
Non-U.S. corporate2,58526(243)2,3692,54818(300)2,266
State and municipal2,881106(184)2,8032,89866(241)2,722
Mortgage and asset-backed4,62339(320)4,3414,44221(290)4,173
Government and agencies1,6413(139)1,5041,1722(147)1,026
Other equity270——270408——408
Non-current investment securities$39,761$1,169$(2,668)$38,262$38,388$781$(3,143)$36,027

The amortized cost of debt securities excludes accrued interest of $490 million and $457 million at March 31, 2023 and December 31, 2022, respectively, which is reported in All other current assets.

The estimated fair value of investment securities at March 31, 2023 increased since December 31, 2022, primarily due to the classification of our remaining equity interest in GE HealthCare within investment securities, new insurance investments, lower market yields and tightening credit spreads, partially offset by AerCap and BKR share sales, and the mark-to-market effect on our equity interest in AerCap.

Total estimated fair value of debt securities in an unrealized loss position were $20,685 million and $21,482 million, of which $14,044 million and $3,275 million had gross unrealized losses of $(2,344) million and $(835) million and had been in a loss position for 12 months or more at March 31, 2023 and December 31, 2022, respectively. At March 31, 2023, the majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology, energy and insurance industries. In addition, gross unrealized losses on our Mortgage and asset-backed securities included $(194) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(125) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not likely that we will be required to sell the investments before recovery of their amortized cost basis.

Net unrealized gains (losses) for equity securities with readily determinable fair values, which are recorded in Other income (loss) within continuing operations, were $6,040 million and $(370) million for the three months ended March 31, 2023 and 2022, respectively.

Proceeds from debt and equity securities sales and early redemptions by issuers totaled $3,008 million and $1,949 million for the three months ended March 31, 2023 and 2022, respectively. Gross realized gains on debt securities were $11 million and $24 million for the three months ended March 31, 2023 and 2022, respectively. Gross realized losses and impairments on debt securities were $(21) million and an insignificant amount for the three months ended March 31, 2023 and 2022, respectively.

2023 1Q FORM 10-Q 28

Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2023 are as follows:

Amortized costEstimated fair value
Within one year$1,057$1,052
After one year through five years4,7624,753
After five years through ten years5,7265,793
After ten years23,32322,052

We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations.

The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $6,379 million and $6,421 million are classified within Level 3, as significant inputs to their valuation models are unobservable at March 31, 2023 and December 31, 2022, respectively. During the three months ended March 31, 2023 and 2022, there were no significant transfers into or out of Level 3.

In addition to the equity securities described above, we hold $714 million and $614 million of equity securities without readily determinable fair values at March 31, 2023 and December 31, 2022, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $9 million and $18 million for the three months ended March 31, 2023 and 2022, respectively.

NOTE 4. CURRENT AND LONG-TERM RECEIVABLES

CURRENT RECEIVABLESMarch 31, 2023December 31, 2022
Customer receivables$11,123$11,803
Revenue sharing program receivables(a)1,3361,326
Non-income based tax receivables1,1901,146
Supplier advances711691
Receivables from disposed businesses245115
Other sundry receivables393518
Allowance for credit losses(b)(787)(768)
Total current receivables$14,212$14,831

(a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties.

(b) Allowance for credit losses increased primarily due to net new provisions of $20 million, partially offset by write-offs, recoveries and foreign currency impact.

March 31, 2023December 31, 2022
Aerospace$7,667$7,784
Renewable Energy2,1292,415
Power3,9404,229
Corporate477404
Total current receivables$14,212$14,831

Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $464 million and $347 million in the three months ended March 31, 2023 and 2022, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement, fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. Included in the sales of customer receivables in the first quarter of 2023, was $77 million in our Gas Power business, primarily for risk mitigation purposes.

LONG-TERM RECEIVABLESMarch 31, 2023December 31, 2022
Long-term customer receivables(a)$448$457
Supplier advances279266
Non-income based tax receivables236213
Financing receivables14782
Sundry receivables429400
Allowance for credit losses(182)(183)
Total long-term receivables$1,358$1,236

(a) The Company sold zero and $79 million of long-term customer receivables to third parties for the three months ended March 31, 2023 and 2022, respectively, primarily in our Gas Power business for risk mitigation purposes.

2023 1Q FORM 10-Q 29

NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS

March 31, 2023December 31, 2022
Raw materials and work in process$10,000$9,191
Finished goods4,2233,937
Deferred inventory costs(a)1,9751,764
Inventories, including deferred inventory costs$16,198$14,891

(a) Represents cost deferral for shipped goods (such as components for wind turbine assemblies within our Renewable Energy segment) and labor and overhead costs on time and material service contracts (primarily originating in Power and Aerospace) and other costs for which the criteria for revenue recognition has not yet been met.

NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES

March 31, 2023December 31, 2022
Original cost$26,957$26,641
Less accumulated depreciation and amortization(16,640)(16,303)
Right-of-use operating lease assets1,8531,854
Property, plant and equipment – net$12,170$12,192

Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities in our Statement of Financial Position, was $2,083 million and $2,089 million, as of March 31, 2023 and December 31, 2022, respectively. Expense on our operating lease portfolio, primarily from our long-term fixed leases, was $195 million and $227 million for the three months ended March 31, 2023 and 2022, respectively.

NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILLJanuary 1, 2023Currency exchange and otherBalance at March 31, 2023
Aerospace$8,835$64$8,899
Renewable Energy3,201423,243
Power144—144
Corporate(a)8182821
Total$12,999$108$13,107

(a) Corporate balance comprises our Digital business.

We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the first quarter of 2023, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Digital reporting unit at Corporate and our Additive reporting unit in our Aerospace segment as the fair value of these reporting units were not significantly in excess of their carrying values based on the results of our most recent annual impairment test, performed in the fourth quarter of 2022. At March 31, 2023, our Digital and Additive reporting units had goodwill of $821 million and $244 million, respectively.

Intangible assets decreased $115 million during the three months ended March 31, 2023, primarily as a result of amortization partially offset by changes in foreign exchange rates of $23 million and additions of capitalized software mainly at Aerospace of $20 million. Consolidated amortization expense was $140 million and $922 million in the three months ended March 31, 2023 and 2022, respectively. Included within consolidated amortization expense for the three months ended March 31, 2022 was a non-cash pre-tax impairment charge of $765 million. For further information on this non-cash pre-tax impairment charge, refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

2023 1Q FORM 10-Q 30

NOTE 8. REVENUES

EQUIPMENT & SERVICES REVENUES
Three months ended March 3120232022
EquipmentServicesTotalEquipmentServicesTotal
Aerospace$1,974$5,007$6,981$1,654$3,949$5,603
Renewable Energy2,3115272,8372,1736982,871
Power1,1022,7183,8209652,5363,501
Total segment revenues$5,387$8,252$13,638$4,792$7,183$11,975
REVENUESThree months ended March 31
20232022
Commercial Engines & Services$5,194$3,853
Military1,0181,036
Systems & Other770714
Aerospace$6,981$5,603
Onshore Wind$1,502$1,906
Grid Solutions equipment and services824668
Offshore Wind, Hydro and Hybrid Solutions511297
Renewable Energy$2,837$2,871
Gas Power$2,867$2,489
Steam Power541636
Power Conversion, Nuclear and other412377
Power$3,820$3,501
Total segment revenues$13,638$11,975
Corporate$848$700
Total revenues$14,486$12,675

REMAINING PERFORMANCE OBLIGATION. As of March 31, 2023, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $242,054 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: (1) equipment-related remaining performance obligation of $47,991 million, of which 55%, 80% and 97% is expected to be satisfied within 1, 2 and 5 years, respectively; and (2) services-related remaining performance obligation of $194,063 million, of which 12%, 43%, 68% and 83% is expected to be recognized within 1, 5, 10 and 15 years, respectively, and the remaining thereafter.

NOTE 9. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME

Contract and other deferred assets decreased $368 million in the three months ended March 31, 2023 primarily due to a decrease in long-term service agreements, partially offset by the timing of revenue recognition ahead of billing milestones on long-term equipment contracts. Our long-term service agreements decreased primarily due to billings of $3,155 million, partially offset by revenues recognized of $2,579 million and net favorable changes in estimated profitability of $53 million at Aerospace and net unfavorable changes in estimated profitability of $12 million at Power.

March 31, 2023AerospaceRenewable EnergyPowerCorporateTotal
Revenues in excess of billings$2,603$—$5,317$—$7,920
Billings in excess of revenues(7,288)—(1,807)—(9,095)
Long-term service agreements$(4,685)$—$3,510$—$(1,176)
Short-term and other service agreements45612966277927
Equipment contract revenues271,0091,457—2,493
Current contract assets$(4,203)$1,138$5,032$277$2,244
Nonrecurring engineering costs(a)2,521192—2,542
Customer advances and other(b)2,389—700—3,089
Non-current contract and other deferred assets$4,910$19$702$—$5,631
Total contract and other deferred assets$707$1,157$5,734$277$7,875

2023 1Q FORM 10-Q 31

December 31, 2022AerospaceRenewable EnergyPowerCorporateTotal
Revenues in excess of billings$2,363$—$5,403$—$7,766
Billings in excess of revenues(6,681)—(1,763)—(8,443)
Long-term service agreements$(4,318)$—$3,640$—$(677)
Short-term and other service agreements39110856245799
Equipment contract revenues429551,348—2,345
Current contract assets$(3,884)$1,063$5,044$245$2,467
Nonrecurring engineering costs(a)2,513174—2,534
Customer advances and other(b)2,519—724—3,243
Non-current contract and other deferred assets$5,032$17$728$—$5,776
Total contract and other deferred assets$1,148$1,079$5,772$245$8,244

(a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced.

(b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements.

Progress collections and deferred income increased $461 million primarily due to new collections received in excess of revenue recognition at Power and Renewable Energy, partially offset by net liquidations at Aerospace. Revenues recognized for contracts included in a liability position at the beginning of the year were $4,468 million and $3,997 million for the three months ended March 31, 2023 and 2022, respectively.

March 31, 2023AerospaceRenewable EnergyPowerCorporateTotal
Progress collections on equipment contracts$90$2,313$4,349$—$6,751
Other progress collections5,6313,0714511319,284
Current deferred income21620412119550
Progress collections and deferred income$5,937$5,588$4,812$249$16,586
Non-current deferred income1,18320698121,500
Total Progress collections and deferred income$7,120$5,794$4,910$262$18,086
December 31, 2022
Progress collections on equipment contracts$74$2,464$3,973$—$6,511
Other progress collections5,7402,7315411319,143
Current deferred income23320813107562
Progress collections and deferred income$6,047$5,404$4,527$238$16,216
Non-current deferred income1,110183104121,409
Total Progress collections and deferred income$7,157$5,586$4,632$250$17,625

NOTE 10. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method and other investments, long-term customer and sundry receivables (see Note 4), cash and cash equivalents and receivables in our run-off insurance operations and prepaid taxes and other deferred charges. All other non-current assets increased $412 million in the three months ended March 31, 2023, primarily due to an increase in equity method and other investments of $180 million, an increase in long-term receivables of $122 million and an increase in Insurance cash and cash equivalents of $68 million. Insurance cash and cash equivalents was $687 million and $619 million at March 31, 2023 and December 31, 2022, respectively.

2023 1Q FORM 10-Q 32

NOTE 11. BORROWINGS

March 31, 2023December 31, 2022
Current portion of long-term borrowings
Senior notes issued by GE$609$464
Senior and subordinated notes assumed by GE9471,973
Senior notes issued by GE Capital5921,188
Other114115
Total short-term borrowings$2,262$3,739
Senior notes issued by GE$4,653$4,724
Senior and subordinated notes assumed by GE8,3838,406
Senior notes issued by GE Capital6,2626,289
Other861901
Total long-term borrowings$20,159$20,320
Total borrowings$22,421$24,059

The Company has provided a full and unconditional guarantee on the payment of the principal and interest on all senior and subordinated outstanding long-term debt securities issued by subsidiaries of GE Capital, our former financial services business. This guarantee applied to $3,379 million and $5,258 million of senior notes and other debt issued by GE Capital at March 31, 2023 and December 31, 2022, respectively. See Note 21 for further information about borrowings and associated hedges.

NOTE 12. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES

March 31, 2023December 31, 2022
Trade payables$10,049$10,033
Supply chain finance programs3,4543,689
Equipment project payables(a)1,1091,236
Non-income based tax payables451441
Accounts payable and equipment project payables$15,063$15,399

(a) Primarily related to projects in our Power and Renewable Energy segments.

We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $2,079 million and $1,856 million for the three months ended March 31, 2023 and 2022, respectively.

NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $791 million and $764 million, profit was $70 million and $106 million and net earnings was $54 million and $84 million for the three months ended March 31, 2023 and 2022, respectively. For the years ended December 31, 2022 and 2021 our insurance operations (net of eliminations) generated revenues of $2,957 million and $3,101 million, profit was $205 million and $798 million and net earnings was $159 million and $627 million, respectively. These operations were supported by assets of $47,981 million, $45,031 million and $56,037 million at March 31, 2023, December 31, 2022 and 2021, respectively. A summary of our insurance liabilities and annuity benefits is presented below:

March 31, 2023Long-term careStructured settlement annuitiesLifeOther contracts(a)Total
Future policy benefit reserves$26,054$9,349$1,045$428$36,876
Investment contracts—846—8211,667
Other——178361539
Total$26,054$10,194$1,223$1,610$39,082
December 31, 2022
Future policy benefit reserves$24,256$8,860$1,040$437$34,593
Investment contracts—860—8491,708
Other——178365544
Total$24,256$9,720$1,218$1,651$36,845

2023 1Q FORM 10-Q 33

December 31, 2021Long-term careStructured settlement annuitiesLifeOther contracts(a)Total
Future policy benefit reserves$34,644$12,328$1,301$490$48,763
Investment contracts—950—9071,857
Other——189761950
Total$34,644$13,278$1,490$2,158$51,570

(a) As of December 31, 2021, Other includes reserves of $325 million related to short-duration contracts at EIC, net of eliminations.

The following tables summarize balances of and changes in future policy benefits reserves.

March 31, 2023March 31, 2022
Present value of expected net premiumsLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Balance, beginning of year$4,059$—$4,828$5,652$—$6,622
Beginning balance at locked-in discount rate3,958—5,2104,451—5,443
Effect of changes in cash flow assumptions——————
Effect of actual variances from expected experience29—(35)(130)—2
Adjusted beginning of year balance3,987—5,1754,321—5,445
Interest accrual53—5059—52
Net premiums collected(103)—(73)(113)—(83)
Effect of foreign currency——(23)——73
Ending balance at locked-in discount rate3,937—5,1294,267—5,487
Effect of changes in discount rate assumptions281—(149)696—396
Balance, end of year$4,217$—$4,979$4,963$—$5,883
Present value of expected future policy benefits
Balance, beginning of year$28,316$8,860$5,868$40,296$12,328$7,923
Beginning balance at locked-in discount rate27,0268,7906,24727,4659,0246,560
Effect of changes in cash flow assumptions(11)—————
Effect of actual variances from expected experience30(1)2(130)(3)19
Adjusted beginning of year balance27,0468,7896,25027,3359,0216,579
Interest accrual3631156036511962
Benefit payments(309)(174)(138)(274)(162)(148)
Effect of foreign currency——(24)——77
Ending balance at locked-in discount rate27,1008,7306,14827,4258,9786,570
Effect of changes in discount rate assumptions3,171619(123)7,8521,870488
Balance, end of year$30,271$9,349$6,025$35,277$10,848$7,058
Net future policy benefit reserves$26,054$9,349$1,045$30,314$10,848$1,175
Less: Reinsurance recoverables, net of allowance for credit losses(204)—(57)(5,154)—(81)
Net future policy benefit reserves, after reinsurance recoverables$25,850$9,349$988$25,160$10,848$1,094

2023 1Q FORM 10-Q 34

December 31, 2022December 31, 2021
Present value of expected net premiumsLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Balance, beginning of year$5,652$—$6,622$6,397$—$7,205
Beginning balance at locked-in discount rate4,451—5,4434,822—5,518
Effect of changes in cash flow assumptions(9)—91(91)—191
Effect of actual variances from expected experience(290)—6(68)—(69)
Adjusted beginning of year balance4,152—5,5404,663—5,640
Interest accrual223—203241—203
Net premiums collected(417)—(357)(453)—(392)
Effect of foreign currency——(176)——(9)
Ending balance at locked-in discount rate3,958—5,2104,451—5,443
Effect of changes in discount rate assumptions101—(381)1,201—1,179
Balance, end of year$4,059$—$4,828$5,652$—$6,622
Present value of expected future policy benefits
Balance, beginning of year$40,296$12,328$7,923$43,974$13,531$8,767
Beginning balance at locked-in discount rate27,4659,0246,56027,7459,1636,797
Effect of changes in cash flow assumptions(413)(23)120(509)58207
Effect of actual variances from expected experience(320)(11)40(147)(11)(43)
Adjusted beginning of year balance26,7328,9906,72027,0899,2106,961
Interest accrual1,4464712431,435491248
Benefit payments(1,152)(671)(531)(1,058)(678)(638)
Effect of foreign currency——(185)——(10)
Ending balance at locked-in discount rate27,0268,7906,24727,4659,0246,560
Effect of changes in discount rate assumptions1,29070(380)12,8313,3051,363
Balance, end of year$28,316$8,860$5,868$40,296$12,328$7,923
Net future policy benefit reserves$24,256$8,860$1,040$34,644$12,328$1,301
Less: Reinsurance recoverables, net of allowance for credit losses(171)—(67)(6,473)—(87)
Net future policy benefit reserves, after reinsurance recoverables$24,085$8,860$973$28,171$12,328$1,214

The Statement of Earnings (Loss) for the three months ended March 31, 2023 and 2022, included gross premiums or assessments of $214 million and $229 million and interest accretion of $435 million and $436 million, respectively. For the three months ended March 31, 2023 and 2022, gross premiums or assessments was substantially all related to long-term care of $124 million and $123 million and life of $84 million and $98 million while interest accretion was substantially all related to long-term care of $310 million and $306 million and structured settlement annuities of $115 million and $119 million, respectively.

The Statement of Earnings (Loss) for the years ended December 31, 2022 and 2021, included gross premiums or assessments of $935 million and $967 million and interest accretion of $1,735 million and $1,730 million, respectively. For the years ended December 31, 2022 and 2021, gross premiums or assessments was substantially all related to long-term care of $490 million and $487 million and life of $415 million and $448 million while interest accretion was substantially all related to long-term care of $1,224 million and $1,194 million and structured settlement annuities of $471 million and $491 million, respectively.

The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses for nonparticipating traditional contracts.

March 31, 2023March 31, 2022December 31, 2022December 31, 2021
UndiscountedDiscounted(a)UndiscountedDiscounted(a)UndiscountedDiscounted(a)UndiscountedDiscounted(a)
Long-term care
Gross premiums$7,924$5,105$8,052$5,599$7,985$4,918$8,173$6,187
Benefit payments64,94430,27167,25435,27765,21728,31667,51640,296
Structured settlement annuities
Benefit payments19,7459,34920,48210,84819,9368,86020,66612,328
Life
Gross premiums13,5376,10414,6767,31113,7545,91614,5798,275
Benefit payments11,8006,02512,7097,05812,0205,86812,7027,923

(a) Determined using the current discount rate as of March 31, 2023 and 2022 and December 31, 2022 and 2021.

2023 1Q FORM 10-Q 35

The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits.

March 31, 2023March 31, 2022December 31, 2022December 31, 2021
Long-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLifeLong-term careStructured settlement annuitiesLife
Duration (years)(a)13.211.25.314.612.26.113.010.75.015.513.26.3
Interest accretion rate5.5%5.4%5.1%5.5%5.4%5.1%5.5%5.4%4.9%5.3%5.5%4.8%
Current discount rate5.0%5.0%4.8%4.0%4.0%3.8%5.6%5.5%5.4%3.1%3.1%2.6%

(a) Duration determined using the current discount rate as of March 31, 2023 and 2022 and December 31, 2022 and 2021.

We completed our annual review of future policy benefit reserves cash flow assumptions in our run-off insurance portfolio in the third quarter of 2022 and 2021. As a result of our 2022 review, we made changes to assumptions, principally related to assumed moderately higher near-term mortality related to COVID-19. Our 2021 review resulted in changes to our assumptions principally related to favorable adjustments to long-term care claim continuance and utilization, unfavorable emerging lapse experience associated with 20-year level term life policies following the end of their 20-year level premium period, and unfavorable structured settlement annuity mortality at older ages for impaired lives.

Included in Insurance losses and annuity benefits in our Statement of Earnings (Loss) for the years ended December 31, 2022 and 2021 are favorable pre-tax adjustments of $404 million and $408 million, respectively, from updating the net premium ratio after updating for actual historical experience each quarter and updating of future cash flow assumptions in the third quarter of each year. Included in these amounts for the years ended December 31, 2022 and 2021, are unfavorable adjustments of $190 million and $58 million, respectively, due to insufficient gross premiums (i.e., net premium ratio exceeded 100%), related to certain cohorts in our long-term care and life insurance portfolios in 2022 and our life portfolio in 2021. These adjustments are primarily attributable to adverse claim experience and delays in premium rate increase approvals in our long-term care insurance portfolio and moderately higher mortality experience and assumption changes related to COVID-19 in our life insurance portfolio.

At March 31, 2023 and 2022, policyholders account balances totaled $1,921 million and $2,095 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the three months ended March 31, 2023 and 2022, are primarily attributed to surrenders, withdrawals, and benefit payments of $120 million and $115 million, partially offset by net additions from separate accounts and interest credited of $75 million and $81 million, respectively. Interest on policyholder account balances is being credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both March 31, 2023 and 2022.

At December 31, 2022 and 2021, policyholders account balances totaled $1,964 million and $2,124 million. As our insurance operations are in run-off, changes in policyholder account balances for the years ended December 31, 2022 and 2021, are primarily attributed to surrenders, withdrawals, and benefit payments of $441 million and $475 million, partially offset by net additions from separate accounts and interest credited of $271 million and $326 million, respectively. Interest on policyholder account balances is being credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both December 31, 2022 and 2021.

Reinsurance recoverables, net of allowances are included in non-current All other assets in our Statement of Financial Position, and amounted to $277 million, $255 million and $6,596 million at March 31, 2023 and December 31, 2022 and 2021, respectively. Allowances at March 31, 2023 and December 31, 2022 were insignificant and were $2,065 million at December 31, 2021.

In the third quarter of 2022, we agreed to terminate substantially all long-term care insurance exposures previously ceded to a single reinsurance company (recapture transaction) and recorded an increase to our allowance for credit losses on such reinsurance recoverables of $350 million (pre-tax) ($276 million (after-tax)) which is unrelated to changes in claim experience or projections of future policy benefit reserves. Upon closing of the recapture transaction in the fourth quarter of 2022, we received a net portfolio of investment securities with an estimated fair value of $2,396 million in complete settlement of reinsurance recoverables previously recognized under retrocession agreements with the reinsurance company, which represented substantially all of our reinsurance recoverables balance as of September 30, 2022 and recorded an incremental loss of $55 million (pre-tax) ($43 million (after-tax)).

The recapture transaction reduces both our financial and operational risks by removing the future inherent risk of collectability of reinsurance recoverables, eliminating retrocession contracts having complex terms and conditions, assuming direct control of the portfolio of investment securities held in a trust for our benefit and redeploying those assets consistent with our portfolio realignment strategy and establishing administration service standards intended to enhance claim administration and innovation efforts. The effect of the recapture agreement does not increase our long-term care insurance liabilities as under the existing retrocession agreements we were not previously relieved of our primary obligation to companies from which we originally assumed the liabilities.

Statutory accounting practices, not GAAP, determine the required statutory capital levels of our insurance legal entities. Statutory accounting practices are set forth by the National Association of Insurance Commissioners (NAIC) as well as state laws, regulation and general administrative rules and differ in certain respects from GAAP. We annually perform statutory asset adequacy testing, the results of which may affect the amount or timing of capital contributions from GE to the insurance legal entities.

2023 1Q FORM 10-Q 36

Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department (KID), we provided a total of $13,215 million of capital contributions to our run-off insurance subsidiaries, including $1,815 million in the first quarter of 2023. In accordance with the terms of the 2018 statutory permitted accounting practice, we expect to provide the final capital contribution of approximately $1,820 million in the first quarter of 2024, pending completion of our December 31, 2023 statutory reporting process, which includes asset adequacy testing, subject to ongoing monitoring by KID. GE is a party to capital maintenance agreements with its run-off insurance subsidiaries under which GE is required to maintain their statutory capital levels at 300% of their year-end Authorized Control Level risk-based capital requirements as defined from time to time by the NAIC.

See Notes 1 and 3 for further information related to our run-off insurance operations.

NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2022 for further information about our plans before the Separation. In connection with the Separation, certain of these plans were split into three and net liabilities of approximately $4.0 billion associated with GE’s postretirement benefit plans were transferred to GE HealthCare. Information about the plans remaining with GE after the Separation is provided below.

DESCRIPTION OF OUR PLANS
Plan CategoryParticipantsFundingComments
Principal Pension PlansGE Energy Pension Plan and GE Aerospace Pension PlanCovers U.S. participants ~115,000 retirees and beneficiaries, ~50,000 vested former employees and ~16,500 active employeesOur funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws. We may decide to contribute additional amounts beyond this level.Closed to new participants since 2012. Benefits for employees with salaried benefits were frozen effective January 1, 2021, and thereafter these employees receive increased company contributions in the company sponsored defined contribution plan in lieu of participation in a defined benefit plan (announced October 2019).
GE Energy Supplementary Pension Plan GE Aerospace Supplementary Pension PlanProvides supplementary benefits to higher-level, longer-service U.S. employeesUnfunded. We pay benefits from company cash.The annuity benefit has been closed to new participants since 2011 and has been replaced by an installment benefit (which was closed to new executives after 2020). Benefits for employees who became executives before 2011 were frozen effective January 1, 2021, and thereafter these employees accrue the installment benefit.
Other Pension Plans(a)35 U.S. and non-U.S. pension plans with pension assets or obligations that have reached $50 millionCovers ~42,500 retirees and beneficiaries, ~29,500 vested former employees and ~8,000 active employeesOur funding policy is to contribute amounts sufficient to meet minimum funding requirements under employee benefit and tax laws in each country. We may decide to contribute additional amounts beyond this level. We pay benefits for some plans from company cash.In certain countries, benefit accruals have ceased and/or have been closed to new hires as of various dates.
Principal Retiree Benefit PlansProvides health and life insurance benefits to certain eligible participantsCovers U.S. participants of Power and Renewable Energy (will be part of GE Vernova, GE's portfolio of energy businesses) and Aerospace ~93,500 retirees and dependents and ~15,500 active employeesWe fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion.Participants share in the cost of the healthcare benefits.

(a) Plans for Power and Renewable Energy (will be part of GE Vernova) and Aerospace that reach $50 million. Plans are not removed from the presentation unless part of a disposition or plan termination.

The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss).

2023 1Q FORM 10-Q 37

PRINCIPAL PENSION PLANSThree months ended March 31
20232022
Service cost for benefits earned$21$49
Expected return on plan assets(594)(786)
Interest cost on benefit obligations474517
Net actuarial loss amortization and other(172)363
Net periodic expense (income)(271)143
Less discontinued operations$—$49
Continuing operations – net periodic expense (income)$(271)$94

Principal retiree benefit plans income was $36 million for the three months ended March 31, 2023 and $52 million, of which $33 million is from continuing operations, for the three months ended March 31, 2022. Other pension plans income was $29 million for the three months ended March 31, 2023 and $117 million, of which $89 million is from continuing operations, for the three months ended March 31, 2022.

We also have a defined contribution plan for eligible U.S. employees that provides employer contributions. Defined contribution plan costs were $77 million for the three months ended March 31, 2023 and $110 million, of which $79 million is from continuing operations, for the three months ended March 31, 2022.

Post Separation, we expect to pay approximately $230 million in total for benefit payments under our GE Energy Supplementary Pension Plan and GE Aerospace Supplementary Pension Plan and administrative expenses of our principal pension plans and expect to contribute approximately $100 million to other pension plans in 2023. We fund retiree health benefits on a pay-as-you-go basis and the retiree life insurance trust at our discretion. Post Separation, we would expect to contribute approximately $230 million in 2023 to fund such benefits.

NOTE 15. CURRENT AND ALL OTHER LIABILITIES. All other current liabilities and All other liabilities primarily includes liabilities for customer sales allowances, equipment project and commercial liabilities, loss contracts, employee compensation and benefits, income taxes payable and uncertain tax positions, operating lease liabilities (see Note 6), environmental, health and safety remediations and product warranties (see Note 23). All other current liabilities increased $183 million in the three months ended March 31, 2023, primarily due to taxes payable of $175 million, sales discounts and allowances of $135 million and equipment projects and other commercial liabilities of $120 million partially offset by derivative instruments of $195 million. All other liabilities decreased $125 million in the three months ended March 31, 2023, primarily due to decreased equipment projects and other commercial liabilities of $181 million.

NOTE 16. INCOME TAXES. Our income tax rate was 4.2% and (2.5)% for the three months ended March 31, 2023 and 2022, respectively. The low tax rate for 2023 was primarily due to the unrealized gain on our investment in GE HealthCare, which is expected to be recovered tax-free. We intend to dispose of our investment in a manner consistent with the tax-free treatment confirmed in our Internal Revenue Service (IRS) ruling in connection with the spin of GE HealthCare. This was partially offset by separation income tax costs including disallowed expenses and valuation allowances related to the spin of GE HealthCare and by losses in foreign jurisdictions that are not likely to be utilized. The tax rate for 2022 reflects a tax provision on a pre-tax loss. The rate was negative primarily due to non-tax benefited asset impairment charges, losses in foreign jurisdictions that are not likely to be utilized and the net unrealized capital loss on our interest in AerCap and Baker Hughes for which the loss could not be tax benefited.

On August 16, 2022, the U.S. enacted the Inflation Reduction Act that includes a new Corporate Alternative Minimum Tax (CAMT) based upon financial statement income, an excise tax on stock buybacks and tax incentives for energy and climate initiatives, among other provisions. The new CAMT is expected to slow but not eliminate the favorable tax impact of our deferred tax assets, resulting in higher cash tax in some years that would generate future tax benefits. The impact of CAMT will depend on our facts in each year and anticipated guidance from the U.S. Department of the Treasury. We currently do not expect to incur CAMT in 2023.

The IRS is currently auditing our consolidated U.S. income tax returns for 2016-2018.

2023 1Q FORM 10-Q 38

NOTE 17. SHAREHOLDERS’ EQUITY

Three months ended March 31
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Dividends per share in dollars)20232022
Beginning balance$(5,893)$(4,569)
AOCI before reclasses – net of taxes of $(5) and $90152(181)
Reclasses from AOCI – net of taxes of $(626) and $0(a)2,234—
AOCI2,387(181)
Less AOCI attributable to noncontrolling interests(1)(4)
Currency translation adjustments AOCI$(3,505)$(4,746)
Beginning balance$6,531$3,646
AOCI before reclasses – net of taxes of $(13) and $25(84)54
Reclasses from AOCI – net of taxes of $(594) and $55(a)(2,235)186
AOCI(2,319)240
Less AOCI attributable to noncontrolling interests(2)2
Benefit plans AOCI$4,214$3,884
Beginning balance$(1,927)$5,172
AOCI before reclasses – net of taxes of $188 and $(801)718(2,993)
Reclasses from AOCI – net of taxes of $0 and $1(a)(12)(5)
AOCI706(2,998)
Investment securities and cash flow hedges AOCI$(1,222)$2,174
Beginning balance$(983)$(9,109)
AOCI before reclasses – net of taxes of $(477) and $979(1,793)3,682
AOCI(1,793)3,682
Long-duration insurance contracts AOCI$(2,776)$(5,427)
AOCI at March 31$(3,289)$(4,115)
Dividends declared per common share$0.08$0.08

(a)The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in three months ended March 31, 2023 related to the spin-off of GE HealthCare.

Preferred stock. GE preferred stock shares outstanding were 2,795,444 and 5,795,444 at March 31, 2023 and December 31, 2022, respectively. We redeemed $3,000 million of GE Series D preferred stock in the first quarter of 2023.

Common stock. GE common stock shares outstanding were 1,088,960,029 and 1,089,107,878 at March 31, 2023 and December 31, 2022, respectively. For further information on our common and preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

NOTE 18. EARNINGS PER SHARE INFORMATION

Three months ended March 3120232022
(Earnings for per-share calculation, shares in millions, per-share amounts in dollars)DilutedBasicDilutedBasic
Earnings (loss) from continuing operations$6,242$6,248$(1,224)$(1,224)
Preferred stock dividends and other(a)(145)(145)(52)(52)
Earnings (loss) from continuing operations attributable to common shareholders6,0976,103(1,276)(1,276)
Earnings (loss) from discontinued operations1,2571,2578888
Net earnings (loss) attributable to GE common shareholders7,3547,360(1,188)(1,188)
Shares of GE common stock outstanding1,0891,0891,1001,100
Employee compensation-related shares (including stock options)8———
Total average equivalent shares1,0971,0891,1001,100
Earnings (loss) per share from continuing operations$5.56$5.60$(1.16)$(1.16)
Earnings (loss) per share from discontinued operations1.151.150.080.08
Net earnings (loss) per share6.716.76(1.08)(1.08)
Potentially dilutive securities(b)3843

(a) For the three months ended March 31, 2023, included $(30) million related to excise tax on preferred share redemption.

(b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended March 31, 2023, application of this treatment had an insignificant effect. For the three months ended March 31, 2022, as a result of the loss from continuing operations, losses were not allocated to the participating securities.

2023 1Q FORM 10-Q 39

NOTE 19. OTHER INCOME (LOSS)

Three months ended March 31
20232022
Licensing and royalty income$34$57
Equity method income—38
Investment in GE HealthCare unrealized gain (loss)6,093—
Investment in and note with AerCap realized and unrealized gain (loss)(195)(1,736)
Investment in Baker Hughes realized and unrealized gain (loss)101,515
Other net interest and investment income (loss)18693
Other items(48)82
Total other income (loss)$6,081$49

Our investment in GE HealthCare comprises 90.3 million shares (approximately 19.9% ownership interest) at March 31, 2023. Our investment in AerCap comprises 79.7 million ordinary shares (approximately 33% ownership interest) at March 31, 2023 and an AerCap senior note. During the first quarter of 2023, we received total proceeds of $1,808 million from the sale of AerCap shares. During the first quarter of 2023, we received proceeds of $216 million from the sale of Baker Hughes shares and have now fully monetized our position.

NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS

RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate.

Three months ended March 31
RESTRUCTURING AND OTHER CHARGES20232022
Workforce reductions$66$13
Plant closures & associated costs and other asset write-downs8226
Acquisition/disposition net charges and other129
Total restructuring and other charges$161$48
Cost of equipment/services$36$27
Selling, general and administrative expenses12525
Other (income) loss—(3)
Total restructuring and other charges$161$48
Aerospace$4$5
Renewable Energy656
Power1934
Corporate723
Total restructuring and other charges$161$48
Restructuring and other charges cash expenditures$137$127

An analysis of changes in the liability for restructuring follows.

20232022
Balance at January 1$977$825
Additions869
Payments(87)(115)
Effect of foreign currency and other—(9)
Balance at March 31(a)$976$710

(a) Includes actuarial determined post-employment severance benefits reserve of $353 million and $322 million as of March 31, 2023 and 2022, respectively. Also includes $64 million reserve in discontinued operations related to a GE technology contract which is indemnified by GE HealthCare as of March 31, 2023.

2023 1Q FORM 10-Q 40

For the three months ended March 31, 2023, restructuring and other initiatives primarily included exit activities related to the restructuring program announced in the fourth quarter of 2022 reflecting lower Corporate shared-service and footprint needs as a result of the GE HealthCare spin-off. It also includes exit activities associated with the plan announced in the fourth quarter of 2022 to undertake a restructuring program across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. We recorded total charges of $161 million, consisting of $75 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $86 million primarily in employee workforce reduction and contract related charges, which are reflected in the table above. We incurred $137 million in cash outflows related to restructuring actions, primarily for employee severance payments.

For the three months ended March 31, 2022, restructuring and other initiatives primarily included exit activities at our Power business related to our new coal build wind-down actions announced in the third quarter of 2021, which included the exit of certain product lines, closing certain manufacturing and office facilities, and workforce reduction programs. We recorded total charges of $48 million, consisting of $39 million primarily in non-cash impairment, accelerated depreciation and other charges, not reflected in the table above, and $9 million primarily in employee workforce reduction charges, which are reflected in the table above. We incurred $127 million in cash outflows related to restructuring actions, primarily for employee severance payments.

SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we expect to incur separation, transition, and operational costs, which will depend on specifics of the transactions.

For the three months ended March 31, 2023, we incurred pre-tax separation expense of $205 million and paid $204 million in cash primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to three stand-alone public companies. These costs are presented as separation costs in our consolidated Statement of Earnings (Loss). In addition, we incurred $56 million of net tax expense, including taxes associated with planned legal entity restructuring and changes to indefinite reinvestment of foreign earnings. For the three months ended March 31, 2022, we incurred pre-tax separation costs of $99 million, spent $3 million in cash, and recognized $24 million of net tax expense related to separation activities.

As discussed in Note 2, GE completed the previously announced separation of its HealthCare business into a separate, independent publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). As a result, pre-tax separation costs specifically identifiable to GE HealthCare are now reflected in discontinued operations. We incurred $20 million in pre-tax costs and recognized $4 million of tax benefits for both the three months ended March 31, 2023 and 2022, and spent $85 million in cash related to GE HealthCare for the three months ended March 31, 2023.

NOTE 21. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2.

March 31, 2023December 31, 2022
Carrying amount (net)Estimated fair valueCarrying amount (net)Estimated fair value
AssetsLoans and other receivables$2,427$2,275$2,557$2,418
LiabilitiesBorrowings (Note 11)$22,421$21,586$24,059$22,849
Investment contracts (Note 13)1,6671,7361,7081,758

Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments.

DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices.

2023 1Q FORM 10-Q 41

FAIR VALUE OF DERIVATIVESMarch 31, 2023December 31, 2022
Gross NotionalAll other assetsAll other liabilitiesGross NotionalAll other assetsAll other liabilities
Currency exchange contracts$4,648$138$100$5,112$132$146
Derivatives accounted for as hedges$4,648$138$100$5,112$132$146
Currency exchange contracts$58,595$917$871$51,885$946$1,082
Interest rate contracts30——43—1
Other contracts652154985819713
Derivatives not accounted for as hedges$59,277$1,071$880$52,786$1,143$1,095
Gross derivatives$63,925$1,208$980$57,898$1,275$1,241
Netting and credit adjustments$(756)$(755)$(821)$(820)
Net derivatives recognized in statement of financial position$452$225$454$420

FAIR VALUE HEDGES. As of March 31, 2023, all fair value hedges were terminated due to exposure management actions, including debt maturities. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the hedged borrowings mature. The cumulative amount of hedging adjustments of $1,226 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,817 million. At March 31, 2022, the cumulative amount of hedging adjustments of $1,931 million (including $2,011 million on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $15,636 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings.

CASH FLOW HEDGES AND NET INVESTMENT HEDGES

Gain (loss) recognized in AOCIThree months ended March 31
20232022
Cash flow hedges(a)$28$(47)
Net investment hedges(b)(62)112

(a) Primarily related to currency exchange contracts.

(b) The carrying value of foreign currency debt designated as net investment hedges was $3,398 million and $3,934 million as of March 31, 2023 and 2022, respectively. The total reclassified from AOCI into earnings was zero for both the three months ended March 31, 2023 and 2022.

Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $25 million loss as of March 31, 2023. We expect to reclassify $8 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. As of March 31, 2023, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years.

The table below presents the gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss):

Three months ended March 31, 2023Three months ended March 31, 2022
RevenuesInterest ExpenseSG&AOther(a)RevenuesInterest ExpenseSG&AOther(a)
$14,486$269$2,142$16,810$12,675$387$2,725$9,823
Effect of cash flow hedges$1$(2)$—$(2)$3$(7)$—$(32)
Hedged items78
Derivatives designated as hedging instruments(87)
Effect of fair value hedges$(9)
Currency exchange contracts$2$—$76$(47)$1$(68)$(81)
Interest rate, commodity and equity contracts(b)—39(11)1(37)15
Effect of derivatives not designated as hedges$2$—$115$(58)$1$—$(105)$(66)

(a) Amounts are inclusive of cost of sales and other income (loss).

(b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities. These hedging programs were to offset the earnings impact of the underlying.

2023 1Q FORM 10-Q 42

COUNTERPARTY CREDIT RISK. Our exposures to counterparties were $325 million and $306 million at March 31, 2023 and December 31, 2022, respectively. Counterparties' exposures to our derivative liability were $170 million and $365 million at March 31, 2023 and December 31, 2022, respectively.

NOTE 22. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $404 million and $401 million and liabilities of $192 million and $206 million at March 31, 2023 and December 31, 2022, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

Our investments in unconsolidated VIEs were $6,088 million and $5,917 million at March 31, 2023 and December 31, 2022, respectively. Of these investments, $1,462 million and $1,481 million were owned by EFS, comprising equity method investments, primarily renewable energy tax equity investments, at March 31, 2023 and December 31, 2022, respectively. In addition, $4,411 million and $4,219 million were owned by our run-off insurance operations, primarily comprising equity method investments at March 31, 2023 and December 31, 2022, respectively. The increase in investments in unconsolidated VIEs in our run-off insurance operations reflects strategic initiatives to invest in higher-yielding asset classes. Our maximum exposure to loss in respect of unconsolidated VIEs is increased by our commitments to make additional investments in these entities described in Note 23.

NOTE 23. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES

COMMITMENTS. We had total investment commitments of $3,966 million at March 31, 2023. The commitments primarily comprise investments by our run-off insurance operations in investment securities and other assets of $3,868 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,761 million. See Note 22 for further information.

As of March 31, 2023, in our Aerospace segment, we have committed to provide financing assistance of $2,390 million of future customer acquisitions of aircraft equipped with our engines.

GUARANTEES. Indemnification agreements - Discontinued Operations. Following the Separation of GE HealthCare on January 3, 2023, GE has remaining performance and bank guarantees on behalf of its former HealthCare business. Under the Separation Distribution Agreement (SDA) entered into by the Company and GE HealthCare in connection with the Separation, GE HealthCare is obligated to use reasonable best efforts to replace GE as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), GE could be obligated to make payments under the applicable instruments. Under the SDA, GE HealthCare is obligated to reimburse and indemnify GE for any such payments. As of March 31, 2023, GE’s maximum aggregate exposure under such credit support instruments was $76 million. Most of these guarantees are not expected to remain in effect as of December 31, 2023. GE also has obligations under the Transition Services Agreement to indemnify GE HealthCare for certain of its technology costs of $70 million, which are expected to be incurred by GE HealthCare within the first year following the Separation and are fully reserved, and under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs of $47 million, which are fully reserved. In addition, we have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $706 million with related reserves of $76 million.

Indemnification agreements – Continuing Operations. GE has obligations under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs and other indemnifications of $49 million, which are fully reserved. In addition, we have $520 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $78 million.

For information on credit support agreements, see our Annual Report on Form 10-K for the year ended December 31, 2022.

PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,932 million and $1,960 million at March 31, 2023 and December 31, 2022, respectively.

LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2022; refer to that discussion for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated.

2023 1Q FORM 10-Q 43

Alstom legacy legal matters. In 2015, we acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $420 million and $455 million at March 31, 2023 and December 31, 2022, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and our ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided.

Bank BPH. As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. At March 31, 2023, approximately 86% of the Bank BPH portfolio is indexed to or denominated in foreign currencies (primarily Swiss francs), and the total portfolio had a carrying value, net of reserves, of $1,126 million. We continue to observe an increase in the number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods.

We estimate potential losses for Bank BPH in connection with borrower litigation cases that are pending by recording legal reserves, as well as in connection with potential future cases or other adverse developments as part of our ongoing valuation of the Bank BPH portfolio, which we record at the lower of cost or fair value, less cost to sell. At March 31, 2023, the total amount of estimated losses was $1,540 million. We update our assumptions underlying the amount of estimated losses based primarily on the number of lawsuits filed and estimated to be filed in the future, whether liability will be established in lawsuits and the nature of the remedy ordered by courts if liability is established. The increase in the amount of estimated losses during the first quarter of 2023 was driven primarily by increased findings of liability and increases in the number of lawsuits filed. We expect the trends we have previously reported of an increasing number of lawsuits being filed and estimated to be filed in the future, more findings of liability and more severe remedies being ordered against Polish banks (including Bank BPH) to continue in future reporting periods, although Bank BPH is unable at this time to develop a meaningful estimate of reasonably possible losses associated with active and inactive Bank BPH mortgage loans beyond the amounts currently recorded. Additional factors may also affect our estimated losses over time, including: potentially significant judicial decisions or binding resolutions by the European Court of Justice (ECJ) or the Polish Supreme Court; the impact of any of these or other future or recent decisions or resolutions (including an expected ECJ ruling that could adversely impact the remedy cost to Polish banks upon a finding of liability and encourage more borrower lawsuits) on how Polish courts will interpret and apply the law in particular cases and how borrower behavior may change in response, neither of which are known immediately upon the issuance of a decision or resolution; financial, economic and other conditions in Poland that may adversely affect borrowers; uncertainty related to a proposal by the Chairman of the Polish Financial Supervisory Authority in December 2020 that banks voluntarily offer borrowers an opportunity to convert their foreign currency indexed or denominated mortgage loans to Polish zlotys using an exchange rate applicable at the date of loan origination, and about the success of the various settlement strategies or other approaches that Polish banks have increasingly adopted or will adopt, or that Bank BPH may adopt in the future, in response to this proposal, regulatory encouragement or other factors, the approaches that regulators and other government authorities will adopt in response, the receptivity of borrowers to settlement offers; the financial and capital impact on banks that adopt settlement programs; the ability of banks, including Bank BPH, to continue collecting installment payments under existing loans, including principal, interest and foreign exchange margins; the ability of banks, including Bank BPH, to recover from borrowers the original principal amount of loans invalidated by Polish courts; and any potential legislation that may be passed in Poland relating to foreign exchange indexed or denominated mortgage loans. In addition, there is continued uncertainty arising from investigations of the Polish Office of Competition and Consumer Protection (UOKiK), including existing or anticipated UOKiK and court decisions resulting from those investigations, particularly UOKiK's investigation into the adequacy of disclosure of foreign exchange risk by banks (including Bank BPH) and the legality under Polish law of unlimited foreign exchange risk on customers. Future changes related to any of the foregoing or in Bank BPH's approach, or other adverse developments such as actions by regulators, legislators or other governmental authorities (including UOKiK), likely would have a material adverse effect on Bank BPH as well as result in additional required capital contributions to Bank BPH or significant losses beyond the amounts that we currently estimate.

ENVIRONMENTAL, HEALTH AND SAFETY MATTERS. For further information about environmental, health and safety matters, see our Annual Report on Form 10-K for the year ended December 31, 2022.

2023 1Q FORM 10-Q 44

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits